Angela K Lucas-Herald1, Esther Kinning, Aritoshi Iida, Zheng Wang, Noriko Miyake, Shiro Ikegawa, Jane McNeilly, S Faisal Ahmed. 1. Developmental Endocrinology Research Group (A.K.L.-H., S.F.A.), School of Medicine, University of Glasgow, Royal Hospital for Sick Children (RHSC), Yorkhill, Glasgow, G3 8SJ United Kingdom; Department of Clinical Genetics (E.K.), Southern General Hospital, Glasgow, G51 4TF United Kingdom; Laboratory of Bone and Joint Diseases (A.I., Z.W., S.I.), Center for Integrative Medical Sciences, RIKEN, Tokyo 108-8639, Japan; Department of Human Genetics (N.M.), Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan; and Department of Biochemistry (J.M.), Southern General Hospital, 1345 Govan Rd, Glasgow, G51 4TF United Kingdom.
Abstract
CONTEXT: Ciliopathies are a group of rare conditions that present through a wide range of manifestations. Given the relative common occurrence of defects of the GH/IGF-I axis in children with short stature and growth retardation, the association between ciliopathies and these defects needs further attention. CASE: Our patient is a boy who was born at term and noted to have early growth retardation and weight gain within the first 18 months of life. Biochemical tests demonstrated low IGF-I but a normal peak GH on stimulation and an adequate increase in IGF-I on administration of recombinant human growth hormone (rhGH). A magnetic resonance imaging scan revealed pituitary hypoplasia and an ectopic posterior pituitary. His growth responded well to rhGH therapy. Subsequently he also developed a retinopathy of his rods and cones, metaphyseal dysplasia, and hypertension with renal failure requiring renal replacement therapy. Whole-exome sequencing demonstrated compound heterozygous mutations of IFT172, thus consistent with a ciliopathy. CONCLUSIONS: This is the first reported case of a child with a mutation in IFT172 who presented with growth retardation in early childhood and was initially managed as a case of functional GH deficiency that responded to rhGH therapy. This case highlights the importance of ciliary function in pituitary development and the link between early onset growth failure and ciliopathies.
CONTEXT: Ciliopathies are a group of rare conditions that present through a wide range of manifestations. Given the relative common occurrence of defects of the GH/IGF-I axis in children with short stature and growth retardation, the association between ciliopathies and these defects needs further attention. CASE: Our patient is a boy who was born at term and noted to have early growth retardation and weight gain within the first 18 months of life. Biochemical tests demonstrated low IGF-I but a normal peak GH on stimulation and an adequate increase in IGF-I on administration of recombinant humangrowth hormone (rhGH). A magnetic resonance imaging scan revealed pituitary hypoplasia and an ectopic posterior pituitary. His growth responded well to rhGH therapy. Subsequently he also developed a retinopathy of his rods and cones, metaphyseal dysplasia, and hypertension with renal failure requiring renal replacement therapy. Whole-exome sequencing demonstrated compound heterozygous mutations of IFT172, thus consistent with a ciliopathy. CONCLUSIONS: This is the first reported case of a child with a mutation in IFT172 who presented with growth retardation in early childhood and was initially managed as a case of functional GH deficiency that responded to rhGH therapy. This case highlights the importance of ciliary function in pituitary development and the link between early onset growth failure and ciliopathies.
Authors: Priya R Gupta; Nachiket Pendse; Scott H Greenwald; Mihoko Leon; Qin Liu; Eric A Pierce; Kinga M Bujakowska Journal: Hum Mol Genet Date: 2018-06-01 Impact factor: 6.150
Authors: Joshi Stephen; Thierry Vilboux; Luhe Mian; Chulaluck Kuptanon; Courtney M Sinclair; Deniz Yildirimli; Dawn M Maynard; Joy Bryant; Roxanne Fischer; Meghana Vemulapalli; James C Mullikin; Marjan Huizing; William A Gahl; May Christine V Malicdan; Meral Gunay-Aygun Journal: Hum Genet Date: 2017-02-20 Impact factor: 4.132
Authors: Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper Journal: Endocr Rev Date: 2016-11-09 Impact factor: 19.871
Authors: Michal Pruski; Ling Hu; Cuiping Yang; Yubing Wang; Jin-Bao Zhang; Lei Zhang; Ying Huang; Ann M Rajnicek; David St Clair; Colin D McCaig; Bing Lang; Yu-Qiang Ding Journal: Front Cell Dev Biol Date: 2019-11-26
Authors: Birgit Weiss; Birgit Eberle; Ralph Roeth; Christiaan de Bruin; Julian C Lui; Nagarajan Paramasivam; Katrin Hinderhofer; Hermine A van Duyvenvoorde; Jeffrey Baron; Jan M Wit; Gudrun A Rappold Journal: Front Endocrinol (Lausanne) Date: 2021-06-04 Impact factor: 5.555
Authors: Johanna Hietamäki; Louise C Gregory; Sandy Ayoub; Anna-Pauliina Iivonen; Kirsi Vaaralahti; Xiaonan Liu; Nina Brandstack; Andrew J Buckton; Tiina Laine; Johanna Känsäkoski; Matti Hero; Päivi J Miettinen; Markku Varjosalo; Emma Wakeling; Mehul T Dattani; Taneli Raivio Journal: J Clin Endocrinol Metab Date: 2020-06-01 Impact factor: 6.134